Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Spondyloarthritis family · A closer look at PsA

Newly diagnosed with PsA: your first steps

Build a shared plan for treatment, monitoring and daily life, with clear questions for the next appointment.

Olga Goodman, MD · Sources checked 27 September 2026

Chapter 4 of 21

The essentials

The first task is to understand your pattern of disease and agree on a plan you can follow. Record a baseline, discuss treatment goals, arrange safety checks and set a review date. Effective care aims to control inflammation and protect function while addressing symptoms and the practical realities of treatment.

Build your baseline

Ask which manifestations are currently active: peripheral joints, entheses, swollen digits, axial symptoms, skin and nails. Keep a concise record of swelling, morning stiffness, sleep and activities you want to regain. Include previous treatments, meaningful benefit, adverse effects and any gaps in access. 1, 2

A baseline is a comparison point, not a prediction of your future. Someone else’s severe images do not determine your prognosis. If the diagnosis remains provisional, ask what supports it and what will be reassessed.

Agree on a clinical target and a personal goal

Clinical goals include remission or, when appropriate, low disease activity, with regular assessment and adjustment. Add a concrete personal goal such as walking to work, using your hands comfortably or sleeping with fewer interruptions. These goals complement examination and other measures; they do not replace them. 6

Ask what improvement is expected and when the treatment should be reviewed. Medicines differ in onset and in which manifestations they treat. Do not assume that reduced pain proves inflammation is controlled, or that every remaining symptom means the medicine has failed.

Understand why this treatment was chosen

The choice depends on active manifestations, severity, previous response, associated conditions, safety factors and your preferences. A medicine suited to peripheral joints may not adequately address axial disease, skin or bowel inflammation. Tell the team about eye or bowel disease, infections, other illnesses, pregnancy plans and all medicines or supplements. 2, 6

Ask whether a treatment mainly relieves symptoms or is intended to modify inflammatory disease. Discuss the expected benefit, important risks, alternatives and the risk of leaving active disease uncontrolled. Unnecessary delay in effective treatment can have consequences; concerns deserve a timely conversation, not silent discontinuation. 1, 6

Make the safety plan practical

Depending on the proposed medicine and your circumstances, preparation may include blood tests, infection screening, vaccination review and pregnancy-related advice. Not every drug needs the same tests. Confirm who reviews results, when monitoring is due and whom to contact about infection, surgery or a missed dose. 2, 6

Keep the prescribed schedule in writing. Use the Medication Guides for practical details about a medicine already selected with your clinician. Avoid doubling a missed dose, sharing medicines or changing steroids without advice. If cost or approval delays prevent treatment, tell the team so the plan can be adjusted.

Know who is responsible for what

The rheumatologist evaluates musculoskeletal inflammation; the dermatologist contributes to skin and nail care. Primary care helps coordinate general health and cardiovascular or metabolic risk management. Physiotherapy or occupational therapy can support movement, pacing and adaptation. Eye or bowel symptoms may need other specialists. 1, 2

Ask who is the main contact and how the different clinicians will exchange information. Keep one current medication list. This publication is an educational resource; messages about your own treatment belong with your care team through its usual channels.

RV-PSA-03 · The Flare Line-Up — Free after registration →

At review: compare, explain, adjust

Bring changes since baseline, including benefits, new problems, laboratory results and whether doses were actually taken. Difficulty obtaining or tolerating medicine is different from failure despite adequate treatment. Improvement in one area with persistent activity elsewhere calls for a broader reassessment. 2, 6

Persistent pain or fatigue may reflect inflammation, established damage, mechanical problems, sleep or other conditions. Describe the impact and ask what evidence supports the explanation. Do not simply endure persistent swelling, declining function or a worsening pattern until a distant routine visit.

RV-PSA-04 · Aim for the Bullseye — Free after registration →

Prepare the next appointment

Write down your three priorities, current doses, relevant photographs and one or two examples of changed function. Agree on the next review date and the route for earlier contact. The existing Visit Planner can help you organise this without creating a separate diary system.

Seek urgent same-day eye assessment for a painful red eye, light sensitivity or a change in vision. A newly hot swollen joint, particularly with rapid deterioration or feeling unwell, needs prompt evaluation for infection or another acute cause. Fever is not required for this to be urgent. 4

Talking to your doctor: fact or myth? — Free after registration →

Shields up: infections and vaccines on treatment — Free after registration →

The road to target — Free after registration →

Go deeper

Why the first prescription is part of an ongoing strategy

Treat-to-target means agreeing on a goal, assessing progress and changing the plan when needed. It is not a promise that every symptom will disappear immediately, and it does not mean staying indefinitely on an ineffective approach.

The discussion should distinguish persistent objective inflammation from other contributors to symptoms, while taking both seriously. Shared decisions include your priorities, practical access and safety. Any later reduction of therapy requires an individual plan and follow-up rather than stopping because one good day or one normal blood test seems reassuring. 6

Questions for your visit

  1. Which manifestations are we treating now?
  2. What is our target, and when will we assess it?
  3. Which tests and precautions apply to my medicine?
  4. Whom should I contact if treatment is delayed, poorly tolerated or not helping?
  5. What would justify changing the plan?

When to seek urgent help

A painful red eye, light sensitivity or a sudden change in vision needs urgent assessment. A newly hot, swollen joint, especially with fever or feeling unwell, also needs prompt assessment.

Sources & evidence notes

Sources checked 27 September 2026

  1. NIAMS. Psoriatic arthritis: overview, diagnosis and care (2024).
  2. Coates LC et al. GRAPPA recommendations 2021. Nature Reviews Rheumatology (2022).
  3. NICE CG153. Psoriasis: assessment and management. Sections 1.2.2.1–1.2.2.3.
  4. NICE NG65. Spondyloarthritis: diagnosis and management. Recognition, referral and diagnosis.
  5. Taylor W et al. CASPAR classification criteria. Arthritis & Rheumatism (2006).
  6. Gossec L et al. EULAR recommendations: 2023 update. Annals of the Rheumatic Diseases (2024).

Educational information for patients and caregivers. This personal publication is not the clinic portal and does not provide individual diagnosis or treatment. Discuss medication changes with your own care team.

© 2026 Olga Goodman, MD · A RheumaView publication. Copying without attribution prohibited.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: PsoriasisPsoriatic arthritisSpondyloarthritis